The research revealed 5 risk factors for stroke for patients with migraine with aura.
A simple risk score prediction model has been developed to determine stroke risk in adults who experience migraine with aura, according to preliminary research.
The research was presented at the American Association’s International Stroke Conference 2020 this past week in Los Angeles, California. Researchers used data from the Atherosclerosis Risk in Communities Cohort (ARIC), a community-based group of people from 4 localities, including Forsyth County, North Carolina; Jackson, Mississippi; Washington County, Maryland; and suburbs of Minneapolis, Minnesota. The group of individuals had been followed and monitored since 1987.
"People who have migraine with aura are at increased risk for an ischemic stroke," Souvik Sen, MD, MPH, study co-author, and professor and chair of the neurology department at the University of South Carolina School of Medicine, said in a statement. "With our new risk-prediction tool, we could start identifying those at higher risk, treat their risk factors and lower their risk of stroke."
In total, 429 adults with a history of migraine with aura and in their 50s at first visit were evaluated. The researchers’ analysis revealed 5 risk factors for stroke and they created a prediction model with each factor assigned a number of points proportional to its influence.
These points included:
The researchers classified each participant into 1 of 3 groups: low-risk (0 to 4 points), intermediate-risk (5 to 10 points), and high-risk (11 to 21 points).
The main results showed that 32 people experienced stroke over the course of 18 years of follow-up. Specifically, at the end of 18 years, 3% in the low-risk group, 8% in the intermediate-risk group, and 34% in the high-risk group had a stroke. Additionally, when compared to the low-risk group, migraine with aura sufferers in the high-risk group were about 7 times more likely to have a stroke, according to the results.
The researchers concluded that the new prediction tool must be validated in a larger population.
Reference
Trivedi T, Vezzetti A, Melikov P, et al. Migraine with aura as a risk for ischemic stroke (MARS) risk score. Presented at: International Stroke Conference, Los Angeles, California; February 19-21, 2020. Poster WMP 1177.
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
CGRP Inhibitors: A Promising New Class of Drugs for Migraine
November 14th 2018This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.
Listen